Reasons Into Hantavirus-Related Biotech: 3 Cautions
A hantavirus outbreak can spark biotech chatter, but three solid realities—limited demand, tough development paths, a...
Stock indices move on earnings, policy changes, and macro data. This intro covers the core catalysts that drive daily swings.
23,761 articlesA hantavirus outbreak can spark biotech chatter, but three solid realities—limited demand, tough development paths, a...
The travel sector is retooling pricing and perks as costs rise and consumers push for clarity. Southwest ditched free...
Stocks wobble as a fresh batch of analyst notes lands on top names like Albemarle, American Express and CME Group. He...
The S&P 500 just delivered its just best quarter since 2020, sparking questions about the path ahead. This article br...
A brief 15-word remark from a Federal Reserve governor sparked a big market conversation. This analysis breaks down w...
DoorDash, Figma, and eBay report after market close, sending shares higher in extended trading. This live blog tracks...
A wave of new analyst ratings hits screens Friday, touching auto parts, semiconductors, software and biotech. Upgrade...
Friday Reads offers a disciplined way to close the week. This investing digest blends macro themes, private market pe...
Q1 2026 earnings transcripts reveal more than quarterly numbers. Explore how guidance, margin trends, and management ...
A blockbuster film about risk and wonder offers more than entertainment. This piece translates Steven Spielberg’s Jur...
May data shows a retail sales surge 0.9%, the strongest in three months, signaling resilience in consumer spending an...
BYD again proves it can set records, this time overseas. The question for investors is how long that momentum lasts a...